SFMBT2 and prostate cancer: Metastatic tumors of LNCaP cells expressing shSFMBT2-GFP was observed in the gonad and kidney (Figure 6F and 6G), indicating that knockdown of SFMBT2 promotes prostate cancer metastasis.